The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. If you watch TV, chances are you’ve heard ...

The manufacturer of Otezla has a copay card for people with private or commercial insurance. This card can decrease the copay of your medication. Sometimes, you may need prior authorization from your ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

--Amgen today announced Otezla ® improved measures of disease severity in adults with mild-to-moderate plaque psoriasis regardless of their Body Surface Area affected by the disease, according to ...

After triumphing over Novartis’ Cosentyx in a 2020 psoriasis study, Skyrizi has dished out another serving of competitor-busting data. This time, the AbbVie and Boehringer Ingelheim-partnered biologic ...

Otezla is a prescription medication used to treat psoriatic arthritis, plaque psoriasis, and ulcers from Behçet’s disease. The drug’s price can vary depending on factors like insurance coverage, your ...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Amgen Inc. (NASDAQ: AMGN) recently announced ...

--Amgen today announced new, 52- week results from the Phase 3 SPROUT study examining the use of Otezla ® in children and adolescents aged 6 to 17 years with moderate to severe plaque psoriasis. These ...